Compare MPLX LP (MPLX) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Stryker Corporation — how do they compare? MPLX LP trades at $59.71 (market cap $60.12B), while Stryker Corporation trades at $347.21 (market cap $133.54B). The key difference: Stryker Corporation is far larger — about 2.2× MPLX LP's market cap, and MPLX LP pays the higher dividend (7.26%). Which is the better fit depends on your goals.
| MPLX | SYK | |
|---|---|---|
Market Cap | $60.12B | $133.54B |
Sector | Technology | Technology |
52-Week High | $60.51 | $394.34 |
52-Week Low | $47.80 | $282.58 |
Enterprise Value | $85.22B | $145.01B |
Dividend Yield | 7.26% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $59.76, up 1.81% with a bullish technical outlook. The stock shows strong profitability with a 40.45% net income margin and a P/E of 12.75. Recent Q2 2026 earnings missed expectations, but revenue grew to $11.7B in 2026. The company announced a $2.25 billion senior notes offering on August 10, 2026, to fund growth projects, supporting its fee-based infrastructure model.
Outlook is positive with a consensus price target of $61.50, though risks include rising capital spending and leverage. The dividend yield remains attractive, with a $1.08 distribution declared for H2-2026. Investors should weigh solid cash flow against execution risks in expansion initiatives.
Stryker (SYK) trades at $345.86, up slightly by 0.01% today, with a bullish technical signal and strong analyst support. The company reported a Q2 2026 earnings beat with $3.69 EPS versus $3.49 expected, driven by 9% organic sales growth and recovery from a cyber incident. Fundamentals show robust profitability with a 14.43% net income margin and 16.51% ROE, though valuation ratios like a P/E of 36.08 are elevated.
Outlook remains positive with raised guidance and new product launches like Mako RPS expanding market reach. Key risks include execution challenges post-cyberattack and competitive pressures. The consensus price target of $379.44 implies ~10% upside, supported by 74% buy ratings from analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
